The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with ...
The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
The increase in breast cancer rates among younger patients is occurring as the incidence of other early-onset cancers — ...
"Boy Meets World" star Danielle Fishel said she is finished with radiation treatment for cancer and opened up about the side ...
Danielle Fishel is sharing an update about her health, saying she has completed “active cancer treatment” following her ...
Flossmoor resident and cancer survivor Ann Jackson launched the Center for Food Equity in Medicine at Flossmoor Community ...
51mon MSN
2024 was a year unlike any other for the British royal family, as Fergie, King Charles and Kate Middleton all announced that ...
As supported by data from the phase 3 TROPION-Breast01 trial, datopotamab deruxtecan is now an FDA-approved treatment for ...
Daiichi Sankyo shares rose sharply after the U.S. Food and Drug Administration approved its breast cancer drug Datroway. Shares were recently 8.7% higher at 4,437 yen, equivalent to $28.39, on Monday ...
The approval is based on findings from the phase 3, multicenter, open-label, randomized TROPION-Breast01 trial.
Steph Peacey, 28, was diagnosed with triple negative breast cancer in August last year after she noticed that her left breast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback